Skip to content

Using Health Information Technology (HIT) to Improve Transitions of Complex Elderly Patients From Skilled Nursing Facility (SNF) to Home

Using HIT to Improve Transitions of Complex Elderly Patients From SNF to Home

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01004328
Acronym
RAMPAGEII
Enrollment
626
Registered
2009-10-29
Start date
2011-04-30
Completion date
2013-01-31
Last updated
2014-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Outcomes

Keywords

patient safety, care transitions, therapeutic monitoring, skilled nursing facilities, Adverse outcomes after discharge from a SNF to home

Brief summary

The incidence of drug-induced injury is high in the ambulatory geriatric population, especially for elders with complex healthcare needs during high risk transitions to the ambulatory setting. In a previous study funded by the National Institute on Aging and the Agency for Healthcare Research and Quality \[AHRQ\] (AG 15979), the investigators determined that drug-related injuries occur at a rate of more than 50 per 1000-patient years in older adults in the ambulatory setting and that 28% are preventable. Independent risk factors for adverse drug events among older adults in the ambulatory setting included advanced age, multiple comorbid conditions, and the use of medications requiring close monitoring. In this project, Using HIT to Improve Transitions of Complex Elderly Patients from SNF to Home (1 R18 HS017817), the investigators are testing the use of an electronic medical record (EMR)-based transitional care intervention for complex elderly patients transitioning from subacute care in a skilled nursing facility (SNF) to the ambulatory setting. The growing trend for physicians and other healthcare providers to restrict their practices to single settings and not follow complex patients as they move between settings leaves older patients discharged from subacute care particularly vulnerable. This transition is uniquely challenging because of the complex healthcare needs of this population, who often require outpatient primary care physicians to coordinate with visiting nurses in order to manage complex medication regimens and fluctuating clinical status. To facilitate high-quality transitions from the subacute to the ambulatory setting and support interdisciplinary communication, the investigators will use the EMR to assure that physicians in the ambulatory setting receive key health information and alerts.

Interventions

OTHERIntervention 1: Electronic medical record (EMR)-based transitional care intervention

Electronic delivery of enhanced discharge information to the ambulatory physician with plans for follow-up appointment, notice of any new medications, and recommendations for laboratory monitoring

Sponsors

University of Massachusetts, Worcester
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 65 years and older, * Member of the study site health plan, * Received care from one of the study site's geriatricians during a SNF stay, * Discharged from SNF to home.

Exclusion criteria

* Does not meet inclusion criteria.

Design outcomes

Primary

MeasureTime frame
Prevalence of appropriate monitoring for selected high risk medications at 30 days from the time of SNF discharge.1 year 3 months
Incidence of adverse drug events (ADEs) 45 days after discharge.1 year 3 months
Rate of follow-up to an outpatient provider within 21 days of SNF discharge.1 year 3 months
Rate of SNF readmission and emergency department (ED) within 30 days of discharge.1 year 3 months

Secondary

MeasureTime frame
Determine costs directly related to the development and installation of the HIT-based transitional care intervention3 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026